Literature DB >> 33614663

Potential Roles of Muscle-Derived Extracellular Vesicles in Remodeling Cellular Microenvironment: Proposed Implications of the Exercise-Induced Myokine, Irisin.

Samuel Darkwah1, Eun Jeong Park1, Phyoe Kyawe Myint1, Atsushi Ito1,2, Michael G Appiah1, Gideon Obeng1, Eiji Kawamoto1,3, Motomu Shimaoka1.   

Abstract

Extracellular vesicles (EVs) have emerged as key players of intercellular communication and mediate crosstalk between tissues. Metastatic tumors release tumorigenic EVs, capable of pre-conditioning distal sites for organotropic metastasis. Growing evidence identifies muscle cell-derived EVs and myokines as potent mediators of cellular differentiation, proliferation, and metabolism. Muscle-derived EVs cargo myokines and other biological modulators like microRNAs, cytokines, chemokines, and prostaglandins hence, are likely to modulate the remodeling of niches in vital sites, such as liver and adipose tissues. Despite the scarcity of evidence to support a direct relationship between muscle-EVs and cancer metastasis, their indirect attribution to the regulation of niche remodeling and the establishment of pre-metastatic homing niches can be put forward. This hypothesis is supported by the role of muscle-derived EVs in findings gathered from other pathologies like inflammation and metabolic disorders. In this review, we present and discuss studies that evidently support the potential roles of muscle-derived EVs in the events of niche pre-conditioning and remodeling of metastatic tumor microenvironment. We highlight the potential contributions of the integrin-mediated interactions with an emerging myokine, irisin, to the regulation of EV-driven microenvironment remodeling in tumor metastasis. Further research into muscle-derived EVs and myokines in cancer progression is imperative and may hold promising contributions to advance our knowledge in the pathophysiology, progression and therapeutic management of metastatic cancers.
Copyright © 2021 Darkwah, Park, Myint, Ito, Appiah, Obeng, Kawamoto and Shimaoka.

Entities:  

Keywords:  extracellular vesicles; homing niche; integrins; irisin; muscle; myokines; tissue microenvironment; tumor metastasis

Year:  2021        PMID: 33614663      PMCID: PMC7892973          DOI: 10.3389/fcell.2021.634853

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  5 in total

Review 1.  Physical Exercise Restrains Cancer Progression through Muscle-Derived Factors.

Authors:  Argyro Papadopetraki; Maria Maridaki; Flora Zagouri; Meletios-Athanasios Dimopoulos; Michael Koutsilieris; Anastassios Philippou
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.575

2.  Skeletal muscle-specific overexpression of miR-486 limits mammary tumor-induced skeletal muscle functional limitations.

Authors:  Ruizhong Wang; Brijesh Kumar; Emma H Doud; Amber L Mosley; Matthew S Alexander; Louis M Kunkel; Harikrishna Nakshatri
Journal:  Mol Ther Nucleic Acids       Date:  2022-03-16       Impact factor: 10.183

3.  Modulation of Plasma Proteomic Profile by Regular Training in Male and Female Basketball Players: A Preliminary Study.

Authors:  Rosamaria Militello; Gabriella Pinto; Anna Illiano; Simone Luti; Francesca Magherini; Angela Amoresano; Pietro Amedeo Modesti; Alessandra Modesti
Journal:  Front Physiol       Date:  2022-03-14       Impact factor: 4.566

4.  Differential microRNA profiles of intramuscular and secreted extracellular vesicles in human tissue-engineered muscle.

Authors:  Christopher G Vann; Xin Zhang; Alastair Khodabukus; Melissa C Orenduff; Yu-Hsiu Chen; David L Corcoran; George A Truskey; Nenad Bursac; Virginia B Kraus
Journal:  Front Physiol       Date:  2022-08-25       Impact factor: 4.755

Review 5.  Extracellular vesicle- and particle-mediated communication shapes innate and adaptive immune responses.

Authors:  Fanny A Pelissier Vatter; Michele Cioffi; Samer J Hanna; Ines Castarede; Simone Caielli; Virginia Pascual; Irina Matei; David Lyden
Journal:  J Exp Med       Date:  2021-06-28       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.